NCT07324096 2026-03-19
AI-PACED
Mayo Clinic
Phase NA Not yet recruiting
Clinical Trials
17 trialsNCT06574620 2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA Recruiting
NCT05296421 2024-04-10
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Rutgers, The State University of New Jersey
Phase NA Recruiting
NCT06214533 2024-01-19
CEBOIDS
Sixth Affiliated Hospital, Sun Yat-sen University
Phase NA Unknown
NCT04115527 2023-10-17
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.
Ruijin Hospital
Phase NA Unknown
NCT05611359 2022-11-10
HOPE-1
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting
NCT03257150 2022-08-11
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
University Health Network, Toronto
Phase NA Completed
NCT03012282 2022-07-06
CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer
University of Washington
Phase NA Terminated
NCT02787187 2021-11-23
Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?
Ruijin Hospital
Phase NA Completed
NCT04310111 2021-08-30
EUS-RFA for Unresectable Pancreatic Cancer
First People's Hospital of Hangzhou
Phase NA Completed
NCT04211948 2021-04-09
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
Ruijin Hospital
Phase NA Unknown
NCT04794140 2021-03-11
A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC
The Third Xiangya Hospital of Central South University
Phase NA Unknown
NCT03138213 2020-10-08
Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy
Tongji Hospital
Phase NA Unknown
NCT04164992 2019-11-18
Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) of Not-resectable Pancreatic Cancer
Campus Bio-Medico University
Phase NA Unknown
NCT03687853 2018-09-27
Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery
Peking University Third Hospital
Phase NA Unknown
NCT01911416 2016-06-09
A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer
University of Utah
Phase NA Withdrawn
NCT01879878 2015-05-28
POUDER
Heidelberg University
Phase NA Unknown